Clinical Trial Results: Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 study assessing change in disease activity with oral atogepant in adult Japanese participants with episodic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Atogepant (Atogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2026-06-11